Our Collab Network members are not only experts within their own domain but educators with the research community. Learn more about the discoveries and findings our collaborators are achieving with IDT.
The future of personalized genomics
Manja Meggendorfer is the Head of Molecular Genetics at Munich Leukemia Laboratory (MLL), where she oversees various R&D activities such as the 5,000 genome project, which is aimed at better understanding the genetic factors behind leukemia. She received her Master of Science in Biology from the Ludwig-Maximilians-University in Munich and her PhD. in collaboration with the Helmholtz Center Munich working on gene regulation within the architecture of the cell nucleus. After her post-doctorate, she moved to the field of hematology as a scientist in the department of molecular genetics at MLL. In combination with her MBA in Health Care Management, Manja hopes to improve the diagnostic and prognostic work associated with routine diagnostic approaches for leukemia or lymphoma patients.
Bioinformatician at Geneseeq
Jerry graduated with a BSc in Biotechnology from University of Toronto and obtained an MSc from Brock University in 2021. He works at Geneseeq as a bioinformatician, where he tackles all sorts of oncology-related problems.
In the webinar, three studies utilizing IDT’s custom xGen™ hybridization capture panels with circulating tumor DNA (ctDNA) for the analysis of minimal residual disease (MRD) are presented. Learn how this approach has been used to assist with assessing neoadjuvant or adjuvant therapies, stratifying relapse risk, as well as relapse prior to radiographic imaging in lung and colorectal cancer cases. Bringing these studies into the spotlight, this will encourage researchers to further explore the benefits of MRD analysis within their translational research studies.